The initiative would be implemented at government Covid-19 vaccination centres for 75 days from July 15 to September 30.
PM Modi sent appreciation letters to them, which can be downloaded from their CoWIN login ID.
A majority of people, including children, persistently experience symptoms like brain fog, fatigue and breathlessness ranging from months to years, post a Covid infection.
The government has no role in the price of these medicines and it has not effected any increase in prices and it has no plans to do so, he said.
The daily positivity rate was at 0.17 per cent and 12 children were among the newly infected people, it said, adding that 46,795 samples were tested in the past 24 hours.
The state now has 822 active cases, while 12,76,782 people have recovered from the disease so far, including 107 in the last 24 hours.
The second worst hit country in terms of cases is India (42,993,494 infections and 515,877 deaths), followed by Brazil (29,391,345 infections and 655,557 deaths).
The number of people who have recuperated from the disease surged to 4,24,46,171 and the case fatality rate was recorded as 1.20 per cent.
The active COVID-19 cases in the country has dipped to 54,118 and comprised 0.13 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.68 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,962,953 infections and 515,036 deaths), followed by Brazil (29,056,525 infections and 652,438 deaths).
The country has also administered over 2 crore precaution doses among the eligible beneficiaries. Additionally, over 97 per cent of India's adult population has also received their first dose of vaccine against Covid-19.
The active cases comprise 0.17 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.65 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,951,556 infections and 514,589 deaths), followed by Brazil (28,978,052 infections and 651,522 deaths).
Of 19 antibodies, 17 were ineffective against the BA.2 subvariant. The researchers found that bebtelovimab, the latest monoclonal antibody to receive FDA Emergency Use Authorisation, is the only currently available antibody therapy that can adequately treat all three Omicron subvariants.
A reduction of 22,056 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.